Shandong Weigao Group Medical Polymer Company Limited: Controlling Shareholder Significantly Increases Shareholding
Key Highlights
- Controlling shareholder, Weigao Holding, has made significant open market purchases of the Company’s H shares.
- Total of 14,953,600 H shares acquired by Weigao Holding from 13 May 2026 up to 5 June 2026.
- Total consideration for these purchases amounted to approximately HK\$50.9 million.
- Weigao Holding now holds 2,114,709,276 H shares, representing approximately 46.76% of all issued H shares and 46.27% of total share capital.
In-Depth Details
Shandong Weigao Group Medical Polymer Company Limited (“the Company”, together with its subsidiaries, “the Group”) has announced that its controlling shareholder, Weigao Holding, has increased its stake in the Company through a series of open market purchases.
According to the announcement, Weigao Holding purchased an aggregate of 11,400,800 H shares between 15 May 2026 and the date of the announcement, accounting for approximately 0.25% of both the total issued H shares and the Company’s total issued share capital.
When combined with prior purchases since 13 May 2026, Weigao Holding has acquired a total of 14,953,600 H shares for a total consideration of approximately HK\$50.9 million. This aggregate purchase represents around 0.33% of all issued H shares and of the total issued share capital.
Following these acquisitions, Weigao Holding’s total stake has increased to 2,114,709,276 H shares, which equates to 46.76% of the issued H shares and 46.27% of the entire issued share capital of the Company.
The Company states that this move demonstrates Weigao Holding’s strong confidence in the Group’s long-term prospects and intrinsic value, as well as its solid support for the Group’s ongoing development.
Important Points for Investors
- The significant increase in shareholding by the controlling shareholder is a clear indicator of confidence in the Company’s future, which may have a positive impact on investor sentiment and share price.
- Such purchases in the open market can potentially support the share price and signal to the market that the controlling shareholder considers the current valuation attractive.
- Investors should note that the controlling shareholder now holds a substantial portion of the shares, which may affect liquidity and the potential for future corporate actions.
Board Composition
- Chairman: Mr. Long Jing
- Chief Executive Officer: Mr. Cong Rinan
- Executive Directors: Mr. Lu Junqiang, Mr. Wang Daoming
- Non-executive Directors: Mr. Chen Lin, Mr. Tang Zhengpeng
- Independent Non-executive Directors: Mr. Li Guohui, Mrs. Meng Hong, Mr. Li Qiang, Mr. Sun Heng
Investor Caution
Shareholders and potential investors are advised to exercise caution when dealing in the securities of the Company.
Disclaimer: The above article is for information purposes only and does not constitute investment advice. Investors are advised to exercise caution and consider their own circumstances before making any investment decisions.
